Home Cart Sign in  
Chemical Structure| 89-00-9 Chemical Structure| 89-00-9

Structure of Quinolinic acid
CAS No.: 89-00-9

Chemical Structure| 89-00-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Quinolinic acid is both a selective agonist at NMDA receptors and also a precursor for the formation of NAD+.

Synonyms: NSC 13127; NSC 403247; NSC 18836

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Quinolinic acid

CAS No. :89-00-9
Formula : C7H5NO4
M.W : 167.12
SMILES Code : O=C(C1=NC=CC=C1C(O)=O)O
Synonyms :
NSC 13127; NSC 403247; NSC 18836
MDL No. :MFCD00006295
InChI Key :GJAWHXHKYYXBSV-UHFFFAOYSA-N
Pubchem ID :1066

Safety of Quinolinic acid

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Rat cerebral cortex slices 10 µM to 5 mM 15 minutes To study the effect of quinolinic acid on basal endogenous amino acid release, results showed no significant effect Br J Pharmacol. 1988 Apr;93(4):868-76
Rat cerebral cortex slices 5 mM 15 minutes To study the effect of quinolinic acid on basal or potassium-evoked [3H]-D-aspartate release, results showed no significant effect Br J Pharmacol. 1988 Apr;93(4):868-76
HMC3 cells 50 µM 24 hours To investigate the restorative effect of UA on QA-induced mitophagy impairment, results showed that UA restores mitophagy by promoting mitolysosome formation. Biol Direct. 2023 Dec 20;18(1):86
HK2 cells 2.5 µM and 5 µM 24 hours To test the effect of QA on kidney tubules, observed a concentration-dependent increase in fibronectin (FN1) and collagen (COL1A2), suggesting QA accumulation may contribute to fibrotic changes in kidney tubules. JCI Insight. 2025 Feb 13;10(6):e180229
Primary cortical neurons 50 µM 24 hours To investigate the effect of quinolinic acid on neurite and dendritic spines in primary cortical neurons, results showed that quinolinic acid reduced neurite length and spine density J Clin Invest. 2023 Feb 15;133(4):e154612
SH-SY5Y cells 50 µM 24 hours To investigate the effect of quinolinic acid on neurite outgrowth in SH-SY5Y cells, results showed that quinolinic acid reduced neurite length J Clin Invest. 2023 Feb 15;133(4):e154612
Human fetal astrocytes 350 nM, 500 nM, 1200 nM 24 hours To investigate whether quinolinic acid induces astrocyte apoptosis. Results showed that after 24 hours of treatment, 10% and 14% of astrocytes underwent apoptosis at 500 nM and 1200 nM concentrations, respectively. J Neuroinflammation. 2005 Jul 26;2:16
BV2 microglial cells 50 µM 72 hours To investigate the effect of QA on mitophagy, results showed that QA impairs mitophagy by inhibiting mitolysosome formation. Biol Direct. 2023 Dec 20;18(1):86
Mouse oligodendroglial cell line N20.1 1 µM 72 hours To assess the toxicity of quinolinic acid on oligodendrocytes and determine LD50 J Neuroinflammation. 2014 Dec 13;11:204
Mouse oligodendroglial cell line N19 0.5 µM 72 hours To assess the toxicity of quinolinic acid on oligodendrocytes and determine LD50 J Neuroinflammation. 2014 Dec 13;11:204

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague Dawley and athymic nude rats Huntington's disease model Intracerebral injection 210 nmol Single administration To evaluate the effects of montelukast (MLK) on QA-induced neuroinflammation and regional metabolic functions J Neuroinflammation. 2023 Feb 13;20(1):34
E. coli K12 MG1655 E. coli K12 MG1655 Shake-flask cultures 40 g/L glucose 37°C, 350 rpm, 4 days Improved quinolinic acid production through metabolic engineering strategies, achieving up to 3.7 g/L in shake-flask cultures. Metab Eng. 2021 Sep;67:164-172
C. elegans SJZ42 foxEx3 [rgef-1p::tomm-20::Rosella] NGM agar plates 5 mM Treatment started from L4 stage, transferred to fresh drug plates every 2 days until day 5 of adulthood. To investigate the effect of QA on healthspan in C. elegans, results showed that QA impairs healthspan by inhibiting mitolysosome formation. Biol Direct. 2023 Dec 20;18(1):86
Wistar rats Anesthetized rat cortical cup model Topical application 5 mM Single application, 10 minutes To study the effect of quinolinic acid on endogenous amino acid release in anesthetized rat cerebral cortex, results showed significant increase in aspartate and glutamate release Br J Pharmacol. 1988 Apr;93(4):868-76
Wistar rats 21-day old rats Intraventricular infusion into the right lateral ventricle 9 mM 7 days QA infusion impaired learning and short-term memory similar to Pb. J Neuroinflammation. 2018 Sep 14;15(1):263
High school and collegiate football players Concussed athlete model Naturally produced Serum Quinolinic acid concentration Approximately 1 day, 8 days, 15 days, and 45 days post-injury To test the hypothesis that the relationship between QuinA in serum and functional connectivity following concussion would depend on the presence of a prior concussion. Results showed a positive association between QuinA and connectivity strength in concussed athletes with prior concussion. Brain Behav Immun. 2021 Jan;91:531-540

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.98mL

1.20mL

0.60mL

29.92mL

5.98mL

2.99mL

59.84mL

11.97mL

5.98mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories